3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
13
cyclopia sequence
7
Neoplasms
6
Multiple Myeloma
6
Fatigue
6
Neoplasms, Plasma Cell
5
Neoplasm Metastasis
4
Lung Neoplasms
4
Dyspnea
4
Carcinoma, Non-Small-Cell Lung
4
Anxiety Disorders
4
Uterine Cervical Neoplasms
3
Tobacco Use Cessation
3
Prostatic Neoplasms
3
Primary Myelofibrosis
3
Leukemia
3
Head and Neck Neoplasms
3
Depression
3
Carcinoma, Renal Cell
3
Vomiting
2
Smoking Cessation
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Polycythemia Vera
2
Parasomnias
2
Pancreatic Neoplasms
2
Pain
2
Osteosarcoma
2
Kidney Neoplasms
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Interventions
Temozolomide
14
Bevacizumab
11
Erlotinib Hydrochloride
5
Radiotherapy
4
Carboplatin
4
Magnetic Resonance Spectroscopy
3
Irinotecan
3
Immunoglobulin G
3
Disulfides
3
temsirolimus
2
poly ICLC
2
palbociclib
2
etoposide phosphate
2
antineoplaston AS 2-1
2
antineoplaston A10
2
Vincristine
2
Sunitinib
2
Sirolimus
2
Everolimus
2
Dasatinib
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
veliparib
1
varlilumab
1
vandetanib
1
trebananib
1
trametinib
1
terameprocol
1
tandutinib
1
selinexor
1
romidepsin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Oligodendroglioma
×
Surveys and Questionnaires
×
Clear all
No trials found.